CN111018807B - Method for synthesizing 1,2, 4-thiadiazole derivative - Google Patents

Method for synthesizing 1,2, 4-thiadiazole derivative Download PDF

Info

Publication number
CN111018807B
CN111018807B CN201911170692.3A CN201911170692A CN111018807B CN 111018807 B CN111018807 B CN 111018807B CN 201911170692 A CN201911170692 A CN 201911170692A CN 111018807 B CN111018807 B CN 111018807B
Authority
CN
China
Prior art keywords
thiadiazole
benzamidine hydrochloride
reaction
dimethyl sulfoxide
cui
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911170692.3A
Other languages
Chinese (zh)
Other versions
CN111018807A (en
Inventor
韩世清
刘雅菲
张育榕
张俊
呼亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN201911170692.3A priority Critical patent/CN111018807B/en
Publication of CN111018807A publication Critical patent/CN111018807A/en
Application granted granted Critical
Publication of CN111018807B publication Critical patent/CN111018807B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Abstract

The invention relates to a method for synthesizing a 1,2, 4-thiadiazole derivative, and belongs to the technical field of chemical preparation. The phenylacetic acid compound and benzamidine hydrochloride compound are taken according to the mass ratio of 1-2: 1 is dissolved in an organic solvent, a catalyst, an oxidant and an alkaline medium are added, and the mixture is stirred for 18 to 24 hours at the temperature of between 130 and 140 ℃ to react to obtain the 1,2, 4-thiadiazole derivative. Cooling, extracting, drying, decompressing, evaporating to remove solvent and performing column chromatography to obtain a pure product. The method for synthesizing the thiadiazole has the following beneficial effects: (1) The reaction condition is milder, the product selectivity is high, and the substrate expansion range is wide. (2) The raw materials used are low in price, low in cost, simple in reaction operation, safe and convenient.

Description

Method for synthesizing 1,2, 4-thiadiazole derivative
Technical Field
The invention relates to the field of organic synthesis, in particular to a method for synthesizing a 1,2, 4-thiadiazole derivative.
Background
Thiadiazole compounds belong to nitrogen heterocyclic compounds, are five-membered nitrogen heterocyclic compounds, contain two nitrogen atoms and one sulfur atom, and have various material functions and medical values. In fact, 1,3, 4-thiadiazoles having a symmetrical structure are the most used in industrial production and pharmaceutical treatment, and there is relatively little research on 1,2, 4-thiadiazoles, which are also widely pharmacologically active and industrially valuable as isomers of 1,3, 4-thiadiazoles having an asymmetric five-membered ring structure. As early as 1968, haruki Eiichi et al synthesized 3, 5-diphenyl-1, 2, 4-thiadiazole from N-chlorobenzamidine and phenylthioamide, but this method had the disadvantage that the substrate had to be synthesized in advance. (Bulletin of the Chemical Society of Japan 1968 41:6, 1361-1367)
In recent years, there have been many reports on methods for synthesizing 1,2, 4-thiadiazole derivatives: for example, the Xu group uses thioamides and aliphatic nitriles as raw materials, and elemental iodine as an oxidant to obtain 1,2, 4-thiadiazole by intramolecular oxidative coupling, with moderate to good yields (org. Biomol. Chem.,2017,15,8410-8417). However, this method has a disadvantage of complicated operation. The method is characterized in that the method takes benzyl bromide, benzamidine hydrochloride and elemental sulfur as initial raw materials and lithium tert-butoxide as auxiliary alkali to synthesize the asymmetric 1,2, 4-thiadiazole. This reaction is very versatile, but the use of lithium t-butoxide is at risk (Tetrahedron Letters,2017, 58 (26), 2571-2573).
Although there are many reports about the synthesis of 1,2, 4-thiadiazole at present, the above methods have some defects, and require expensive substrate raw materials, so that the reaction steps are complicated, the conditions are severe, the yield is low, the post-treatment is difficult, toxic solvents are used, and the high price, the strong toxicity and the dependence on the highly toxic solvents limit the industrial application of the method in many fields.
Disclosure of Invention
The invention aims to provide a method for synthesizing a 1,2, 4-thiadiazole derivative, which provides more choices for industrial production thereof. The method has the advantages of cheap and easily available initial raw materials and wide substrate applicability.
The technical scheme adopted by the invention is as follows: the method comprises the following specific steps: the phenylacetic acid compound and benzamidine hydrochloride compound are taken according to the mass ratio of 1-2: 1 is dissolved in an organic solvent, a catalyst, an oxidant and an alkaline medium are added, and the mixture is stirred for 18 to 24 hours at the temperature of between 130 and 140 ℃ to react to obtain the 1,2, 4-thiadiazole derivative.
The reaction process is as follows:
Figure SMS_1
preferably, the benzamidine hydrochloride compound has the following structural formula
Figure SMS_2
Wherein R is 1 Is one of hydrogen and methyl.
Benzamidine hydrochloride compounds are: benzamidine hydrochloride
Figure SMS_3
4-methylbenzidine hydrochloride
Figure SMS_4
Preferably, the phenylacetic acid compound has the following structural formula:
Figure SMS_6
wherein R is 2 Is one of hydrogen, methyl, methoxy, phenyl or trifluoromethyl. More preferably, the phenylacetic acid compound is: phenylacetic acid->
Figure SMS_8
3-Methylphenylacetic acid->
Figure SMS_10
4-Methylphenylacetic acid->
Figure SMS_7
3-Methoxyphenylacetic acid->
Figure SMS_9
4-Methoxyphenylacetic acid
Figure SMS_11
2-naphthylacetic acid->
Figure SMS_12
3-Trifluoromethylphenylacetic acid
Figure SMS_5
The oxidant is preferably sulfur powder; the mass ratio of the sulfur powder to the benzamidine hydrochloride compound is 4-6: 1.
the alkaline medium is preferably Na 2 CO 3 The method comprises the steps of carrying out a first treatment on the surface of the The ratio of the amount of the alkaline medium to the amount of the substance of the benzamidine hydrochloride compound is 2-3: 1.
the catalyst is preferably CuI, cuBr or Cu (OAc) 2 The method comprises the steps of carrying out a first treatment on the surface of the The ratio of the catalyst to the benzamidine hydrochloride compound is 0.1-0.2: 1.
the solvent is preferably dimethyl sulfoxide (DMSO); the solvent is added in an amount to dissolve the reaction raw materials.
In the technical proposal, the mixture is stirred for 18 to 24 hours at the temperature of 130 to 140 ℃ and then the product is obtained by cooling, extracting, drying and column chromatography separation of the system.
Due to the application of the technical scheme, compared with the prior art, the invention has the following advantages:
1. the reaction condition is simple and mild, the reaction yield is high, and the highest yield can reach 82 percent.
2. Sodium carbonate is used as an alkaline medium, the catalyst is low-cost copper salt, the use amount of the catalyst is only 20% of the amount of benzamidine hydrochloride compound substances, the target product can be obtained by only adding an organic solvent into a reaction system, the increase of the economic cost of the final product is solved, the use amount of the catalyst is small, and the pollution to the environment is reduced; the product is cooled, extracted, dried, decompressed, distilled to remove the solvent and subjected to column chromatography to finish the post-treatment, and the post-treatment is simple and convenient.
3. The established catalytic system has wide applicability, high substrate conversion rate and high product yield, and expands industrial application in various fields.
Detailed Description
The invention is further described below in connection with examples, which are not intended to limit the invention in any way:
example 1:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole as benzamidineHydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_13
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 65 percent, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86 to 88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 2:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_14
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 0.5mmol phenylacetic acid, 2.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 52%, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 3:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_15
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 140℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 60 percent, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 4:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_16
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 18 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 51%, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 5:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_17
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 2.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 55%, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 6:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_18
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.05mmol of CuI, 2mL of dimethyl sulfoxide was added thereto, and the mixture was stirred at 130℃for 24 hours, whereupon the reaction was completed by TLC plate, and a product was formed.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
Yield 57%, of 3, 5-diphenyl-)The melting point of the 1,2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 7:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_19
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.5mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 59 percent, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 8:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 The reaction formulas of the raw materials of CuBr and dimethyl sulfoxide are as follows:
Figure SMS_20
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuBr, 2mL of dimethyl sulfoxide was added thereto, and the mixture was stirred at 130℃for 24 hours, whereupon the reaction was completed by TLC plate, and a product was formed.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 63%, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 9:
this example shows the synthesis of 3, 5-diphenyl-1, 2, 4-thiadiazole using benzamidine hydrochloride, phenylacetic acid, sulfur powder, na 2 CO 3 、Cu(OAc) 2 Dimethyl sulfoxide is used as a raw material, and the reaction formula is as follows:
Figure SMS_21
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol phenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 ,0.1mmol Cu(OAc) 2 2mL of dimethyl sulfoxide was added thereto, and the mixture was stirred at 130℃for 24 hours, whereupon completion of the reaction was detected by TLC plate, and a product was formed.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 64 percent, and the melting point of the 3, 5-diphenyl-1, 2, 4-thiadiazole is 86-88 ℃; nuclear magnetic hydrogen spectrum (500 MHz, CDCl) 3 ):8.41(d,J=6.5Hz,2H),8.05(d,J=6.5Hz,2H),7.57-7.46(m,6H).
Example 10:
this example shows the synthesis of 3-phenyl-5- (m-tolyl) -1,2, 4-thiadiazole using benzamidine hydrochloride, 3-methylphenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_22
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol 3-methylphenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI, 2mL of dimethyl sulfoxide was added thereto, and the mixture was stirred at 130℃for 24 hoursThe reaction was complete as detected by TLC plates with product formation.
The reaction solution was cooled, extracted, dried, distilled under reduced pressure to remove the solvent, and filtered to give a yellow oil.
Yield 50%, nuclear magnetic hydrogen spectrum (500 MHz, CDCl) of the 3-phenyl-5- (m-tolyl) -1,2, 4-thiadiazole 3 ):δ8.40(d,J=6.3Hz,2H),7.88(s,1H),7.84(d,J=7.1Hz,1H),7.50(d,J= 6.8Hz,3H),7.43–7.33(m,2H),2.47(s,3H).
Example 11:
this example shows the synthesis of 3-phenyl-5- (p-tolyl) -1,2, 4-thiadiazole using benzamidine hydrochloride, 4-methylphenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_23
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol 4-methylphenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
The yield is 61%, and the melting point of the 3-phenyl-5- (p-tolyl) -1,2, 4-thiadiazole is 115-116 ℃; nuclear magnetic hydrogen spectrum (300 mhz, cdcl 3): δ8.45-8.34 (m, 2H), 7.95 (d, j=8.0 hz, 2H), 7.50 (d, j=5.5 hz, 3H), 7.32 (d, j=7.9 hz, 2H), 2.44 (s, 3H).
Example 12:
this example shows the synthesis of 3-phenyl-5- (3- (trifluoromethyl) phenyl) -1,2, 4-thiadiazole in the form of benzamidine hydrochloride, 3-trifluoromethylphenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_24
the preparation method comprises the following steps: into a 25mL pressure-resistant tube were charged 0.5mmol benzamidine hydrochloride, 1.0mmol 3-trifluoromethylphenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
Yield 82%, nuclear magnetic hydrogen spectrum (500 mhz, cdcl 3) of the 3-phenyl-5- (3- (trifluoromethyl) phenyl) -1,2, 4-thiadiazole: δ8.41 (d, j=6.3 hz, 2H), 8.34 (s, 1H), 8.22 (d, j=7.8 hz, 1H), 7.81 (d, j=7.8 hz, 1H), 7.67 (t, j=7.8 hz, 1H), 7.52 (d, j=6.5 hz, 3H).
Example 13:
this example shows the synthesis of 5- (3-methoxyphenyl) -3-phenyl-1, 2, 4-thiadiazole in the form of benzamidine hydrochloride, 3-methoxyphenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_25
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol 3-methoxyphenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
Yield 69%, nuclear magnetic hydrogen spectrum (500 MHz, CDCl 3) of the 5- (3-methoxyphenyl) -3-phenyl-1, 2, 4-thiadiazole: δ8.40 (d, j=7.2 hz, 2H), 7.64-7.58 (m, 2H), 7.50 (d, j=7.2 hz, 3H), 7.43 (t, j=7.9 hz, 1H), 7.09 (d, j=9.7 hz, 1H), 3.93 (s, 3H).
Example 14:
this example shows the synthesis of 5- (4-methoxyphenyl) -3-phenyl-1, 2, 4-thiadiazole as benzamidine hydrochloride, 4-methoxyPhenylacetic acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_26
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol 4-methoxyphenylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
Yield 50%, nuclear magnetic hydrogen spectrum (500 MHz, CDCl 3) of the 5- (4-methoxyphenyl) -3-phenyl-1, 2, 4-thiadiazole: δ8.38 (d, j=6.6 hz, 2H), 8.00 (d, j=8.7 hz, 2H), 7.49 (d, j=7.6 hz, 3H), 7.02 (d, j=8.7 hz, 2H), 3.90 (s, 3H).
Example 15:
this example shows the synthesis of 5- (naphthalen-2-yl) -3-phenyl-1, 2, 4-thiadiazole in the form of benzamidine hydrochloride, 2-naphthyridine acid, sulfur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_27
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol benzamidine hydrochloride, 1.0mmol 2-naphthylacetic acid, 3.0mmol sulfur powder, 1.0mmol Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
Yield 77%, melting point of this 5- (naphthalen-2-yl) -3-phenyl-1, 2, 4-thiadiazole is 125-126 ℃; nuclear magnetic hydrogen spectrum (500 mhz, cdcl 3): δ8.58 (s, 1H), 8.44 (d, j=6.8 Hz, 2H), 8.11 (d, j=8.4 Hz, 1H), 7.99 (t, j=7.3 Hz, 2H), 7.90 (d, j=6.1 Hz, 1H), 7.56 (dd, j=35.5, 6.1Hz, 5H).
Example 16:
this example shows the synthesis of 5-phenyl-3- (p-tolyl) -1,2, 4-thiadiazole in the form of 4-methylbenzamidine hydrochloride, phenylacetic acid, sulphur powder, na 2 CO 3 CuI and dimethyl sulfoxide are used as raw materials, and the reaction formula is as follows:
Figure SMS_28
the preparation method comprises the following steps: into a 25mL pressure-resistant tube was charged 0.5mmol of 4-methylbenzamidine hydrochloride, 1.0mmol of phenylacetic acid, 3.0mmol of sulfur powder, 1.0mmol of Na 2 CO 3 0.1mmol of CuI was added with 2mL of dimethyl sulfoxide and stirred at 130℃for 24 hours, and the reaction was completed by TLC plate, resulting in the formation of a product.
The reaction solution is cooled, extracted, dried, decompressed, distilled to remove the solvent, and filtered to obtain white solid.
Yield 63%, nuclear magnetic hydrogen spectrum (500 MHz, CDCl) of the 5-phenyl-3- (p-tolyl) -1,2, 4-thiadiazole 3 ):δ8.30(d,J=8.0Hz,2H),8.05(d,J=7.6Hz,2H),7.52(d,J=7.1Hz,3H), 7.31(d,J=7.8Hz,2H),2.44(s,3H)。

Claims (3)

1. A method for synthesizing 1,2, 4-thiadiazole derivatives comprises the following specific steps: the phenylacetic acid compound and benzamidine hydrochloride compound are taken according to the mass ratio of 1-2: 1, dissolving in an organic solvent, adding a catalyst, an oxidant and an alkaline medium, and stirring at 130-140 ℃ for 18-24 hours to react to obtain a 1,2, 4-thiadiazole derivative; wherein the organic solvent is dimethyl sulfoxide; the oxidant is sulfur powder; the molar ratio of the oxidant to the benzamidine hydrochloride compound is 4-6:1; the alkaline medium is Na 2 CO 3 The method comprises the steps of carrying out a first treatment on the surface of the The molar ratio of the alkaline medium to the benzamidine hydrochloride compound is 2-3:1; the catalyst is CuI, cuBr or Cu (OAc) 2 The method comprises the steps of carrying out a first treatment on the surface of the The mol ratio of the catalyst to the benzamidine hydrochloride compound is 0.1-0.2:1.
2. The method according to claim 1, characterized in that: the structural formula of the benzamidine hydrochloride compound is as follows:
Figure FDA0004044290540000011
wherein R is 1 Is one of hydrogen or methyl.
3. The method according to claim 1, characterized in that: the structural formula of the phenylacetic acid compound is as follows:
Figure FDA0004044290540000012
wherein R is 2 Is one of hydrogen, methyl, methoxy, phenyl or trifluoromethyl. />
CN201911170692.3A 2019-11-26 2019-11-26 Method for synthesizing 1,2, 4-thiadiazole derivative Active CN111018807B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911170692.3A CN111018807B (en) 2019-11-26 2019-11-26 Method for synthesizing 1,2, 4-thiadiazole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911170692.3A CN111018807B (en) 2019-11-26 2019-11-26 Method for synthesizing 1,2, 4-thiadiazole derivative

Publications (2)

Publication Number Publication Date
CN111018807A CN111018807A (en) 2020-04-17
CN111018807B true CN111018807B (en) 2023-04-25

Family

ID=70202140

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911170692.3A Active CN111018807B (en) 2019-11-26 2019-11-26 Method for synthesizing 1,2, 4-thiadiazole derivative

Country Status (1)

Country Link
CN (1) CN111018807B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112321583B (en) * 2020-12-02 2023-05-09 安徽理工大学 Synthesis method of 1,2, 4-thiadiazole compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104072429A (en) * 2014-07-01 2014-10-01 安徽师范大学 Synthetic method of 1,2,4-triazole derivative
CN107846888A (en) * 2015-07-06 2018-03-27 拜耳作物科学股份公司 Heterocyclic compound as insecticide
CN110054593A (en) * 2019-05-16 2019-07-26 南京工业大学 A method of synthesis 1,3,5- pyrrolotriazine derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3275440B1 (en) * 2015-03-25 2022-05-04 National Center for Geriatrics and Gerontology Novel oxadiazole derivative and pharmaceutical containing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104072429A (en) * 2014-07-01 2014-10-01 安徽师范大学 Synthetic method of 1,2,4-triazole derivative
CN107846888A (en) * 2015-07-06 2018-03-27 拜耳作物科学股份公司 Heterocyclic compound as insecticide
CN110054593A (en) * 2019-05-16 2019-07-26 南京工业大学 A method of synthesis 1,3,5- pyrrolotriazine derivatives

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
5-烷基-2-氨基-1,3,4-噻二唑的合成及应用;乐长高等;《化学世界》;20021231(第07期);第366-368页 *
A copper-catalyzed approach for the synthesis of asymmetrical disubstituted 1,2,4-thiadiazoles via elemental sulfur-mediated decarboxylative redox cyclization;Yafei Liu等;《Tetrahedron Letters》;20201229;第65卷;第152744(1-5)页 *
A three-component approach to 3,5-diaryl-1,2,4-thiadiazoles under transition-metal-free conditions;Hao Xie等;《Org. Lett.》;20160408;第18卷;第2196-2199页 *
An alternatively metal-free synthesis of 1,3,5-triazines or 1,2,4-thiadiazoles from benzyl chlorides and benzylamines mediated by elemental sulfur;Yurong Zhang等;《Tetrahedron Letters》;20191017;第60卷;第151289(1-7)页 *
Multicomponent reactions (MCRs) of arylmethyl bromides, arylamidines and elemental sulfur toward unsymmetric 3,5-diaryl 1,2,4-thiadiazoles;Zhen Zhou等;《Tetrahedron Letters》;20170519;第58卷;第2571-2573页 *

Also Published As

Publication number Publication date
CN111018807A (en) 2020-04-17

Similar Documents

Publication Publication Date Title
WO2021169359A1 (en) Benzodihydrofuro heterocyclic compound and preparation method therefor
US10927095B2 (en) Processes for the preparation of Niraparib and intermediates thereof
CN104557800A (en) 2-phenoxyl tetrahydrofuran (tetrahydropyrane) derivatives and application thereof in synthesis of penoxsulam
EP1845084A1 (en) Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)idomethylcyclopropane
CN111018807B (en) Method for synthesizing 1,2, 4-thiadiazole derivative
EP3766869B1 (en) Simple preparation method for avibactam
JPS5919536B2 (en) Method for producing 5-aroyl-1-lower alkylpyrrole-2-acetic acid derivative
KR20020033617A (en) Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof
CN112174763A (en) Racemization method and application of pyridine derivative
EP0086678A1 (en) Process for the preparation of 2-acyl-1,3,4,6,7,11b-2H-hexahydro-4-pyrazino(2,1-a)isoquinolinones and intermediates
CN113248480B (en) Method for chemically and enantioselectively inserting N-H bond of 2-pyridone or 3-pyridazinone into furan carbene
CN114315609A (en) Process for preparing cis-2-aminocyclohexanol
CN115010707A (en) Process for preparing quinolopyrrole derivatives
JP2018135293A (en) Method for producing amide compound
CN107721917B (en) Green synthesis method of polysubstituted nicotinate compound
CN113121401A (en) N-substituted carbonyl fluorosulfonamide compound, preparation method and application thereof
US7078543B2 (en) Methods for producing oxirane carboxylic acids and derivatives thereof
JPH0240365A (en) Production of n-hydroxypyrazole
Dhara et al. An iron-catalyzed domino reaction of donor–acceptor cyclopropanes: a diastereoselective approach towards diversely functionalized pyrrolo-quinazolines
CN114436890B (en) Synthetic method of 3-amino-2-indene carbonitrile compound
CN116283810B (en) Preparation method of isoxazole compound
CN112062785B (en) Preparation method of ozagrel and intermediate thereof
CN110590641B (en) Green preparation method of 3-hydroxyisoindole-1-ketone series compounds
BE858864A (en) NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION
RU2339619C2 (en) Method of obtaining nicotinaldehydes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant